CDC virus expert resigns
Digest more
Top News
Reactions and opinions
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The mRNA-based RSV shot,
A second senior CDC official has resigned in two weeks, citing fears that scientific integrity is being undermined under vaccine sceptic Health and Human Services Secretary Robert F. Kennedy Jr. Dr. Fiona Havers,
3d
Money Talks News on MSNOver 50? You Need These 5 Vaccines, the CDC SaysFor this reason, the CDC recommends adults 50 or older schedule the following vaccines, which many people can get for free. Just talk to your doctor before getting any vaccine, as there are some exceptions to CDC recommendations.
Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The RSV shot,
Explore more
All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing decisions" made by U.S. Health Secretary Robert F. Kennedy Jr. that could lead to more preventable disease spread.
Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’ - Fiona Havers had worked for the Centers of Disease Control for 13 years bef
A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from infectious diseases like COVID-19 has resigned in protest following Health and Human Services Secretary Robert F.
1d
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine,